Author
Listed:
- Chaoyong He
(Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation)
- Shayna C. Medley
(Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center)
- Taishan Hu
(Immune Cell Development and Host Defense, Fox Chase Cancer Center)
- Myron E. Hinsdale
(University of Oklahoma Health Sciences Center
Center for Veterinary Health Sciences, Oklahoma State University)
- Florea Lupu
(University of Oklahoma Health Sciences Center
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation)
- Renu Virmani
(CVPath Institute, Inc.)
- Lorin E. Olson
(Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation
University of Oklahoma Health Sciences Center)
Abstract
Platelet-derived growth factor (PDGF) is a mitogen and chemoattractant for vascular smooth muscle cells (VSMCs). However, the direct effects of PDGF receptor β (PDGFRβ) activation on VSMCs have not been studied in the context of atherosclerosis. Here we present a new mouse model of atherosclerosis with an activating mutation in PDGFRβ. Increased PDGFRβ signalling induces chemokine secretion and leads to leukocyte accumulation in the adventitia and media of the aorta. Furthermore, PDGFRβD849V amplifies and accelerates atherosclerosis in hypercholesterolemic ApoE−/− or Ldlr−/− mice. Intriguingly, increased PDGFRβ signalling promotes advanced plaque formation at novel sites in the thoracic aorta and coronary arteries. However, deletion of the PDGFRβ-activated transcription factor STAT1 in VSMCs alleviates inflammation of the arterial wall and reduces plaque burden. These results demonstrate that PDGFRβ pathway activation has a profound effect on vascular disease and support the conclusion that inflammation in the outer arterial layers is a driving process for atherosclerosis.
Suggested Citation
Chaoyong He & Shayna C. Medley & Taishan Hu & Myron E. Hinsdale & Florea Lupu & Renu Virmani & Lorin E. Olson, 2015.
"PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis,"
Nature Communications, Nature, vol. 6(1), pages 1-14, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8770
DOI: 10.1038/ncomms8770
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8770. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.